These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15570184)

  • 1. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
    Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
    Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
    Prémaud A; Rousseau A; Picard N; Marquet P
    Ther Drug Monit; 2006 Apr; 28(2):274-7. PubMed ID: 16628144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.
    Weber LT; Shipkova M; Armstrong VW; Wagner N; Schütz E; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B
    Clin Chem; 2002 Mar; 48(3):517-25. PubMed ID: 11861442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
    Martiny D; Macours P; Cotton F; Thiry P; Gulbis B
    Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
    De Nicolò A; Ianniello A; Benagli C; Della Bruna R; Keller F; Antonucci M; D'Avolio A; Cantù M
    J Pharm Biomed Anal; 2020 Aug; 187():113337. PubMed ID: 32442868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
    Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Oellerich M; Wieland E
    Clin Chem; 2000 Mar; 46(3):365-72. PubMed ID: 10702523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Kuhn J; Götting C; Kleesiek K
    Talanta; 2010 Mar; 80(5):1894-8. PubMed ID: 20152429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
    Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
    Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay.
    Kuhn J; Prante C; Kleesiek K; Götting C
    Clin Biochem; 2009 Jan; 42(1-2):83-90. PubMed ID: 18996104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay.
    Beal JL; Jones CE; Taylor PJ; Tett SE
    Ther Drug Monit; 1998 Dec; 20(6):685-90. PubMed ID: 9853989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay.
    Hosotsubo H; Takahara S; Imamura R; Kyakuno M; Tanaka T; Yazawa K; Hanafusa T; Matsumiya K; Nonomura N; Okuyama A; Sugimoto H
    Ther Drug Monit; 2001 Dec; 23(6):669-74. PubMed ID: 11802102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus.
    Xu LY; Jiao Z; Liu FY; Qiu XY; Ji L; Zhang M
    Ther Drug Monit; 2018 Oct; 40(5):572-580. PubMed ID: 29847459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine.
    Klepacki J; Klawitter J; Bendrick-Peart J; Schniedewind B; Heischmann S; Shokati T; Christians U; Klawitter J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():113-9. PubMed ID: 21839692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry.
    Annesley TM; Clayton LT
    Clin Chem; 2005 May; 51(5):872-7. PubMed ID: 15746301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a Point-of-Care Testing with Enzyme-Multiplied Immunoassay Technique and Liquid Chromatography Combined With Tandem Mass Spectrometry Methods for Therapeutic Drug Monitoring of Mycophenolic Acid: A Preliminary Study.
    Zhou H; Xiang H; Cai J; Wang Y; Zhang M; Han Y; Zhang Y
    Ther Drug Monit; 2021 Oct; 43(5):630-636. PubMed ID: 33394991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma.
    Patel CG; Akhlaghi F
    Ther Drug Monit; 2006 Feb; 28(1):116-22. PubMed ID: 16418705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma.
    Vergara Chozas JM; Sáez-Benito Godino A; Zopeque García N; García Pinteño S; Joumady I; Carrasco García C; Vara Gil F
    Transplant Proc; 2012 Nov; 44(9):2669-72. PubMed ID: 23146489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolic acid monitoring in HTX patients: a preliminary report.
    Müller MM; Vogl M; Griesmacher A
    Therapie; 1997; 52(4):341-4. PubMed ID: 9437889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.